Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient

Journal of Neurodegenerative Diseases
Amrutha ChilumuriNathaniel G N Milton

Abstract

The pons region of the Alzheimer's disease (AD) brain is one of the last to show amyloid-β (Aβ) deposits and has been suggested to contain neuroprotective compounds. Kisspeptin (KP) is a hormone that activates the hypothalamic-pituitary-gonadal axis and has been suggested to be neuroprotective against Aβ toxicity. The localization of KP, plus the established endogenous neuroprotective compounds corticotropin releasing hormone (CRH) and catalase, in tissue sections from the pons region of a male AD subject has been determined in relation to Aβ deposits. Results showed Aβ deposits also stained with KP, CRH, and catalase antibodies. At high magnification the staining of deposits was either KP or catalase positive, and there was only a limited area of the deposits with KP-catalase colocalization. The CRH does not bind Aβ, whilst both KP and catalase can bind Aβ, suggesting that colocalization in Aβ deposits is not restricted to compounds that directly bind Aβ. The neuroprotective actions of KP, CRH, and catalase were confirmed in vitro, and fibrillar Aβ preparations were shown to stimulate the release of KP in vitro. In conclusion, neuroprotective KP, CRH, and catalase all colocalize with Aβ plaque-like deposits in the pons region ...Continue Reading

References

Oct 1, 1990·Journal of Molecular Endocrinology·N G MiltonA M McGregor
Jan 1, 1987·Annals of the New York Academy of Sciences·E B De SouzaW W Vale
Dec 1, 1995·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S MorenoM P Cerù
Jul 12, 1996·Neuroscience Letters·C SchultzE Braak
Oct 18, 2002·Neuroscience Letters·Nathaniel G N Milton
Dec 14, 2004·The Journal of Comparative Neurology·G Cristina BrailoiuNae J Dun
Jul 6, 2005·Ageing Research Reviews·Dick F SwaabPaul J Lucassen
Jul 28, 2005·Ageing Research Reviews·Nadhim Bayatti, Christian Behl
Apr 28, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Angela M Floden, Colin K Combs
Jun 20, 2006·Biochemical and Biophysical Research Communications·Takeshi FunakoshiYoichi Mizukami
Nov 30, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T S HwangH S Han
Oct 24, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Vincenzo MicaleFilippo Drago
Feb 3, 2009·Acta Neuropathologica·Irina AlafuzoffHans Kretzschmar
Aug 18, 2009·Micron : the International Research and Review Journal for Microscopy·Nathaniel G N Milton, J Robin Harris
Jul 6, 2010·Neuroscience·Y LyubimovP Panula
Mar 3, 2011·Endocrinology·Joshua KimAlexander S Kauffman
Apr 13, 2011·The Journal of Comparative Neurology·Jinyan Cao, Heather B Patisaul
Jul 1, 2005·Environmental Toxicology and Pharmacology·J SamsonM Senthilvelan
Aug 20, 2011·Nature Reviews. Drug Discovery·Eric KarranBart De Strooper
Jan 24, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bradley T HymanThomas J Montine

❮ Previous
Next ❯

Citations

Jun 3, 2021·Pharmaceuticals·Barbara MiziakStanisław J Czuczwar

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.